Back to News
Market Impact: 0.3
Should You Buy Tilray Stock Under $5?
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Tilray reported record revenue and adjusted EBITDA for its recently completed fiscal year, signaling operating improvement. However, the market reaction and investor backdrop remain negative, with shares down nearly 56% year to date despite the record results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
TLRY0.35
More News
- Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?
- CoreWeave seeks truce with Texas Governor-elect Hinojosa
- These funds tout hefty income tied to the tech trade – if you’re willing to deal with the complexity
- Street Calls of The Week
- Meta’s $25 Billion Bond Sale Highlights Shifting Landscape for Tech Debt
- Binance CFO exits days after catastrophic $6 billion crypto hack